Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
West Nile Virus Activity --- United States, August 25--31, 2004
During August 25--31, a total of 210 cases of human West Nile virus (WNV) illness were reported from 14 states
(Arizona, California, Florida, Illinois, Indiana, Kansas, Maryland, Minnesota, Montana, Nevada, New Mexico, North Dakota, Oklahoma, and Pennsylvania).
During 2004, a total of 36 states have reported 1,053 cases of human WNV illness to CDC through ArboNET (Table, Figure). Of these, 326 (31%) cases were reported from
California, 316 (30%) cases were reported from Arizona, and
141 (13%) cases were reported from Colorado. A total of 588 (56%) of the 1,053 cases occurred in males; the median age
of patients was 51 years (range: 1 month--99 years). Illness onset ranged from April 23 to August 24; a total of 28 cases
were fatal.
A total of 85 presumptive West Nile viremic blood donors (PVDs) have been reported to ArboNET in 2004. Of these,
36 (42%) were reported from Arizona, 20 from California, eight from New Mexico, six from Texas, three each from Florida and South Dakota, two from Colorado and Wisconsin, and one each from Illinois, Iowa, Louisiana, Minnesota, and Missouri . Of the 85 PVDs, three persons aged 42, 66 and 69 years subsequently had neuroinvasive illness, and 15 persons (median age: 55 years; range: 17--73 years) subsequently had West Nile fever.
In addition, during 2004, a total of 3,307 dead corvids and 671 other dead birds with WNV infection have
been reported from 44 states. WNV infections have been reported in horses from 31 states (Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Kansas, Kentucky, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Mexico, North Carolina, Ohio, Oklahoma, Oregon, South Dakota, Tennessee, Texas, Utah, Virginia, Wisconsin, West Virginia, and Wyoming) and in five dogs from Nevada and New Mexico. Three unidentified animal species with WNV infection were reported from Illinois, Iowa, and Nevada. WNV seroconversions have been reported in
571 sentinel chicken flocks from 11 states
(Arizona, Arkansas, California, Delaware, Florida, Iowa, Louisiana, Nebraska,
Nevada, South Dakota, and Utah) and in two wild hatchling birds from Ohio. Three seropositive sentinel horses were reported from Puerto Rico. A total of 4,024 WNV-positive mosquito pools have been reported from 31 states (Arizona, Arkansas, California, Colorado, Connecticut, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana,
Maryland, Massachusetts, Michigan, Mississippi, Missouri, Montana, Nebraska, Nevada, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, South Dakota, Tennessee, Texas, Utah, Virginia, and Wisconsin).
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
